Register a trial

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT04437407




Registration number
NCT04437407
Ethics application status
Date submitted
16/06/2020
Date registered
18/06/2020

Titles & IDs
Public title
UniSA BackOff! Study: Adelaide PrenaBelt Trial
Scientific title
UniSA BackOff! Study: A Randomized, Controlled, Five-way, Cross-over Trial to Evaluate the Effect of a Positional Therapy Device on Maternal Sleeping Position in the Third Trimester of Pregnancy
Secondary ID [1] 0 0
202902
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Stillbirth 0 0
Infant, Low Birth Weight 0 0
Infant, Very Low Birth Weight 0 0
Sleep-Disordered Breathing 0 0
Infant, Small for Gestational Age 0 0
Fetal Hypoxia 0 0
Pregnancy Complications 0 0
Fetal Growth Retardation 0 0
Condition category
Condition code
Respiratory 0 0 0 0
Sleep apnoea
Reproductive Health and Childbirth 0 0 0 0
Fetal medicine and complications of pregnancy
Respiratory 0 0 0 0
Other respiratory disorders / diseases
Reproductive Health and Childbirth 0 0 0 0
Childbirth and postnatal care
Reproductive Health and Childbirth 0 0 0 0
Complications of newborn
Reproductive Health and Childbirth 0 0 0 0
Other reproductive health and childbirth disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - PB2-1 prototype
Treatment: Devices - PB2-2 prototype
Treatment: Devices - PB2-3 prototype
Treatment: Devices - PB2-4 prototype
Treatment: Devices - PB2-5 prototype
Treatment: Devices - Ajuvia-Active
Treatment: Devices - Ajuvia-Passive

Other: Control - The first night will be a control night with infrared video recording where only the Ajuvia sleep monitor is worn in passive mode so that each participant can act as her own control for comparison of treatment effect on outcomes.

Experimental: PB2-1 - During this night, the PB2-1 prototype will be worn with the Ajuvia in passive mode.

Experimental: PB2-2 - During this night, the PB2-2 prototype will be worn with the Ajuvia in passive mode.

Experimental: PB2-3 - During this night, the PB2-3 prototype will be worn with the Ajuvia in passive mode.

Experimental: PB2-4 - During this night, the PB2-4 prototype will be worn with the Ajuvia in passive mode.

Experimental: PB2-5 - During this night, the PB2-5 prototype will be worn with the Ajuvia in active mode.


Treatment: Devices: PB2-1 prototype
PB2-1 prototype is a belt-like wearable device similar to the original PrenaBelt designed for pregnant women that permits supine positioning of the pelvis but, when in this position, provides subtle pressure points to the user's body and thereby activates the body's natural mechanism to reposition itself to relieve discomfort. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

Treatment: Devices: PB2-2 prototype
PB2-2 prototype is a belt-like wearable device designed for pregnant women. When placed on the woman's back, this device prevents the pelvis from achieving a supine orientation by maintaining at least fifteen degrees of right or left lateral pelvic tilt. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

Treatment: Devices: PB2-3 prototype
PB2-3 prototype is a belt-like wearable device designed for pregnant women. When placed on the woman's back, this device prevents the pelvis from achieving a supine orientation by maintaining at least fifteen degrees of right or left lateral pelvic tilt. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

Treatment: Devices: PB2-4 prototype
PB2-4 prototype is a belt-like wearable device designed for pregnant women that prevents the user from achieving a supine position as the device allows right and left lateral pelvic tilt but prevents the user's pelvis from settling supine due to virtue of its design. It is expected to significantly decrease the amount of time a pregnant woman's pelvis is in the supine position overnight while promoting comfortable sleep.

Treatment: Devices: PB2-5 prototype
PB2-5 prototype is a belt-like wearable device designed for pregnant women that does not provide positional therapy. It can be worn anytime as a maternity support belt.

Treatment: Devices: Ajuvia-Active
Ajuvia Sleep Monitor senses the user's body position and can be used in passive or active mode with or without the PB2 prototypes. In the active mode, it alerts the woman when her pelvis is in the supine position through a gentle vibratory alarm.

Treatment: Devices: Ajuvia-Passive
Ajuvia Sleep Monitor senses the user's body position and can be used in passive or active mode with or without the PB2 prototypes. In the passive mode, it measures and records the position of the pelvis but does not alert the woman.
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Sensitivity of Ajuvia for supine position
Timepoint [1] 0 0
1 night (approximately 8 hours)
Primary outcome [2] 0 0
Specificity of Ajuvia for supine position
Timepoint [2] 0 0
1 night (approximately 8 hours)
Primary outcome [3] 0 0
Sensitivity of Ajuvia for prone position
Timepoint [3] 0 0
1 night (approximately 8 hours)
Primary outcome [4] 0 0
Specificity of Ajuvia for prone position
Timepoint [4] 0 0
1 night (approximately 8 hours)
Primary outcome [5] 0 0
Sensitivity of Ajuvia for left tilt position
Timepoint [5] 0 0
1 night (approximately 8 hours)
Primary outcome [6] 0 0
Specificity of Ajuvia for left tilt position
Timepoint [6] 0 0
1 night (approximately 8 hours)
Primary outcome [7] 0 0
Sensitivity of Ajuvia for left lateral position
Timepoint [7] 0 0
1 night (approximately 8 hours)
Primary outcome [8] 0 0
Specificity of Ajuvia for left lateral position
Timepoint [8] 0 0
1 night (approximately 8 hours)
Primary outcome [9] 0 0
Sensitivity of Ajuvia for right tilt position
Timepoint [9] 0 0
1 night (approximately 8 hours)
Primary outcome [10] 0 0
Specificity of Ajuvia for right tilt position
Timepoint [10] 0 0
1 night (approximately 8 hours)
Primary outcome [11] 0 0
Sensitivity of Ajuvia for right lateral position
Timepoint [11] 0 0
1 night (approximately 8 hours)
Primary outcome [12] 0 0
Specificity of Ajuvia for right lateral position
Timepoint [12] 0 0
1 night (approximately 8 hours)
Primary outcome [13] 0 0
Supine Sleep Time - Control
Timepoint [13] 0 0
1 night (approximately 8 hours)
Primary outcome [14] 0 0
Supine Sleep Time - PB2-1
Timepoint [14] 0 0
1 night (approximately 8 hours)
Primary outcome [15] 0 0
Supine Sleep Time - PB2-2
Timepoint [15] 0 0
1 night (approximately 8 hours)
Primary outcome [16] 0 0
Supine Sleep Time - PB2-3
Timepoint [16] 0 0
1 night (approximately 8 hours)
Primary outcome [17] 0 0
Supine Sleep Time - PB2-4
Timepoint [17] 0 0
1 night (approximately 8 hours)
Primary outcome [18] 0 0
Supine Sleep Time - PB2-5
Timepoint [18] 0 0
1 night (approximately 8 hours)
Primary outcome [19] 0 0
Prone Sleep Time - Control
Timepoint [19] 0 0
1 night (approximately 8 hours)
Primary outcome [20] 0 0
Prone Sleep Time - PB2-1
Timepoint [20] 0 0
1 night (approximately 8 hours)
Primary outcome [21] 0 0
Prone Sleep Time - PB2-2
Timepoint [21] 0 0
1 night (approximately 8 hours)
Primary outcome [22] 0 0
Prone Sleep Time - PB2-3
Timepoint [22] 0 0
1 night (approximately 8 hours)
Primary outcome [23] 0 0
Prone Sleep Time - PB2-4
Timepoint [23] 0 0
1 night (approximately 8 hours)
Primary outcome [24] 0 0
Prone Sleep Time - PB2-5
Timepoint [24] 0 0
1 night (approximately 8 hours)
Primary outcome [25] 0 0
Left-tilt Sleep Time - Control
Timepoint [25] 0 0
1 night (approximately 8 hours)
Primary outcome [26] 0 0
Left-tilt Sleep Time - PB2-1
Timepoint [26] 0 0
1 night (approximately 8 hours)
Primary outcome [27] 0 0
Left-tilt Sleep Time - PB2-2
Timepoint [27] 0 0
1 night (approximately 8 hours)
Primary outcome [28] 0 0
Left-tilt Sleep Time - PB2-3
Timepoint [28] 0 0
1 night (approximately 8 hours)
Primary outcome [29] 0 0
Left-tilt Sleep Time - PB2-4
Timepoint [29] 0 0
1 night (approximately 8 hours)
Primary outcome [30] 0 0
Left-tilt Sleep Time - PB2-5
Timepoint [30] 0 0
1 night (approximately 8 hours)
Primary outcome [31] 0 0
Left-lateral Sleep Time - Control
Timepoint [31] 0 0
1 night (approximately 8 hours)
Primary outcome [32] 0 0
Left-lateral Sleep Time - PB2-1
Timepoint [32] 0 0
1 night (approximately 8 hours)
Primary outcome [33] 0 0
Left-lateral Sleep Time - PB2-2
Timepoint [33] 0 0
1 night (approximately 8 hours)
Primary outcome [34] 0 0
Left-lateral Sleep Time - PB2-3
Timepoint [34] 0 0
1 night (approximately 8 hours)
Primary outcome [35] 0 0
Left-lateral Sleep Time - PB2-4
Timepoint [35] 0 0
1 night (approximately 8 hours)
Primary outcome [36] 0 0
Left-lateral Sleep Time - PB2-5
Timepoint [36] 0 0
1 night (approximately 8 hours)
Primary outcome [37] 0 0
Right-tilt Sleep Time - Control
Timepoint [37] 0 0
1 night (approximately 8 hours)
Primary outcome [38] 0 0
Right-tilt Sleep Time - PB2-1
Timepoint [38] 0 0
1 night (approximately 8 hours)
Primary outcome [39] 0 0
Right-tilt Sleep Time - PB2-2
Timepoint [39] 0 0
1 night (approximately 8 hours)
Primary outcome [40] 0 0
Right-tilt Sleep Time - PB2-3
Timepoint [40] 0 0
1 night (approximately 8 hours)
Primary outcome [41] 0 0
Right-tilt Sleep Time - PB2-4
Timepoint [41] 0 0
1 night (approximately 8 hours)
Primary outcome [42] 0 0
Right-tilt Sleep Time - PB2-5
Timepoint [42] 0 0
1 night (approximately 8 hours)
Primary outcome [43] 0 0
Right-lateral Sleep Time - Control
Timepoint [43] 0 0
1 night (approximately 8 hours)
Primary outcome [44] 0 0
Right-lateral Sleep Time - PB2-1
Timepoint [44] 0 0
1 night (approximately 8 hours)
Primary outcome [45] 0 0
Right-lateral Sleep Time - PB2-2
Timepoint [45] 0 0
1 night (approximately 8 hours)
Primary outcome [46] 0 0
Right-lateral Sleep Time - PB2-3
Timepoint [46] 0 0
1 night (approximately 8 hours)
Primary outcome [47] 0 0
Right-lateral Sleep Time - PB2-4
Timepoint [47] 0 0
1 night (approximately 8 hours)
Primary outcome [48] 0 0
Right-lateral Sleep Time - PB2-5
Timepoint [48] 0 0
1 night (approximately 8 hours)

Eligibility
Key inclusion criteria
* =18 years old
* low-risk singleton pregnancy
* in the last trimester of pregnancy (at least 28 weeks + 0 days but not more than 36 weeks + 0 days of gestation)
* access to and ability to use iPhone (for downloading and using Ajuvia app)
* residing in the Greater Adelaide Area.
Minimum age
18 Years
Maximum age
No limit
Sex
Females
Can healthy volunteers participate?
Yes
Key exclusion criteria
* musculoskeletal disorder that prevents sleeping supine or on a certain side (e.g., arthritic shoulder)
* non-English speaking and reading

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?


The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Crossover
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Stopped early
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/02/2020
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
15/06/2021
Sample size
Target
Accrual to date
Final
6
Recruitment in Australia
Recruitment state(s)
SA
Recruitment hospital [1] 0 0
UniSA Clinical & Health Sciences - Adelaide
Recruitment postcode(s) [1] 0 0
5000 - Adelaide

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Shiphrah Biomedical Inc.
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
University of South Australia
Address [1] 0 0
Country [1] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Jane Warland, PhD
Address 0 0
University of South Australia
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
No/undecided IPD sharing reason/comment


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.


Results not provided in https://clinicaltrials.gov/study/NCT04437407